Int. J. Mol. Sci. 2013, 14(11), 21513-21524; doi:10.3390/ijms141121513

Neuroprotective Effects of Liraglutide for Stroke Model of Rats

1,2email, 1email, 1,* email, 1email, 2email, 3email, 1email, 1email, 1email, 1email, 1email, 1email, 1email, 4email, 2email and 1email
Received: 2 September 2013; in revised form: 18 October 2013 / Accepted: 23 October 2013 / Published: 30 October 2013
(This article belongs to the Special Issue Pathology and Treatment of Central Nervous System Diseases)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The number of diabetes mellitus (DM) patients is increasing, and stroke is deeply associated with DM. Recently, neuroprotective effects of glucagon-like peptide-1 (GLP-1) are reported. In this study, we explored whether liraglutide, a GLP-1 analogue exerts therapeutic effects on a rat stroke model. Wistar rats received occlusion of the middle cerebral artery for 90 min. At one hour after reperfusion, liraglutide or saline was administered intraperitoneally. Modified Bederson’s test was performed at 1 and 24 h and, subsequently, rats were euthanized for histological investigation. Peripheral blood was obtained for measurement of blood glucose level and evaluation of oxidative stress. Brain tissues were collected to evaluate the level of vascular endothelial growth factor (VEGF). The behavioral scores of liraglutide-treated rats were significantly better than those of control rats. Infarct volumes of liraglutide-treated rats at were reduced, compared with those of control rats. The level of derivatives of reactive oxygen metabolite was lower in liraglutide-treated rats. VEGF level of liraglutide-treated rats in the cortex, but not in the striatum significantly increased, compared to that of control rats. In conclusion, this is the first study to demonstrate neuroprotective effects of liraglutide on cerebral ischemia through anti-oxidative effects and VEGF upregulation.
Keywords: cerebral ischemia; diabetes mellitus; glucagon-like peptide-1; liraglutide; oxidative stress; stroke; VEGF
PDF Full-text Download PDF Full-Text [324 KB, uploaded 19 June 2014 05:14 CEST]

Export to BibTeX |

MDPI and ACS Style

Sato, K.; Kameda, M.; Yasuhara, T.; Agari, T.; Baba, T.; Wang, F.; Shinko, A.; Wakamori, T.; Toyoshima, A.; Takeuchi, H.; Sasaki, T.; Sasada, S.; Kondo, A.; Borlongan, C.V.; Matsumae, M.; Date, I. Neuroprotective Effects of Liraglutide for Stroke Model of Rats. Int. J. Mol. Sci. 2013, 14, 21513-21524.

AMA Style

Sato K, Kameda M, Yasuhara T, Agari T, Baba T, Wang F, Shinko A, Wakamori T, Toyoshima A, Takeuchi H, Sasaki T, Sasada S, Kondo A, Borlongan CV, Matsumae M, Date I. Neuroprotective Effects of Liraglutide for Stroke Model of Rats. International Journal of Molecular Sciences. 2013; 14(11):21513-21524.

Chicago/Turabian Style

Sato, Kenichiro; Kameda, Masahiro; Yasuhara, Takao; Agari, Takashi; Baba, Tanefumi; Wang, Feifei; Shinko, Aiko; Wakamori, Takaaki; Toyoshima, Atsuhiko; Takeuchi, Hayato; Sasaki, Tatsuya; Sasada, Susumu; Kondo, Akihiko; Borlongan, Cesario V.; Matsumae, Mitsunori; Date, Isao. 2013. "Neuroprotective Effects of Liraglutide for Stroke Model of Rats." Int. J. Mol. Sci. 14, no. 11: 21513-21524.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert